Becker's Healthcare September 16, 2024
The market for radiopharmaceuticals has the potential to grow to “tens of billions” if the drugs prove to be effective, according to a Sept. 16 report from CNBC.
Companies including Bristol Myers Squibb, AstraZeneca and Eli Lilly have invested billions in radiopharmaceutical drugs, which target cells containing specific cancer markers with radioactive material, the report said.
“If we can be successful in expanding the...